Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Hilary Tedd (Newcastle, United Kingdom), Hilary Tedd, James Macfarlane, Chris Stenton. Latent TB infection: Patient choices and completion of treatment. Eur Respir J 2016; 48: Suppl. 60, 2719

Member's Comments

No comment yet.

Related content which might interest you: Do we need to screen for latent TB when initiating a methotrexate treatment? Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Impact and management of TB childhood outbreaks in EU/EEA Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013 Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified? Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Source: International Congress 2015 – Screening strategies in TB Year: 2015 Management of tuberculosis (TB) at a district general hospital: An audit of practice Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Knowledge and practices of hospital employees on tuberculosis Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Impact of social support programme on MDR-TB patients' treatment outcomes Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3 Year: 2014 Delay in pulmonary tuberculosis treatment in Croatia Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Recurrent TB in Ireland is predominantly due to relapsed infection and is frequently associated with poor compliance with therapy Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 The causes of death among patients with tuberculosis Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015 Childhood tuberculosis outbreaks in EU/EEA: A systematic review Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Preventive treatment for latent tuberculosis infection Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Impact of drug injection using on TB-AIDS treatment outcomes Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Treatment outcomes of new TB cases among children in Russia Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Home based tuberculosis (TB) care program Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Characteristics of tuberculosis (TB) in patients that died from TB in Poland Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016